Roll, Amy https://orcid.org/0000-0002-5815-3988
Saxena, Malvika
Orlan, Elizabeth
Titus, Angelin
Juvekar, Sanjay Kamlakar
Gwayi-Chore, Marie-Claire
Avokpaho, Euripide
Chabi, Félicien
Togbevi, Comlanvi Innocent
Belou Elijan, Abiguel
Nindi, Providence
Walson, Judd L.
Ajjampur, Sitara S. R.
Ibikounlé, Moudachirou
Kalua, Khumbo
Aruldas, Kumudha
Means, Arianna Rubin
Clinical trials referenced in this document:
Documents that mention this clinical trial
Disability in childhood and the equity of health services: a cross-sectional comparison of mass drug administration strategies for soil-transmitted helminths in southern Malawi
https://doi.org/10.1136/bmjopen-2023-083321
It depends on how you tell: a qualitative diagnostic analysis of the implementation climate for community-wide mass drug administration for soil-transmitted helminth (Pre-results)
https://doi.org/10.1136/bmjopen-2022-061682
Representativeness of a mobile phone-based coverage evaluation survey following mass drug administration for soil-transmitted helminths: a comparison of participation between two cross-sectional surveys
https://doi.org/10.1136/bmjopen-2022-070077
Policy stakeholder perspectives on barriers and facilitators to launching a community-wide mass drug administration program for soil-transmitted helminths
https://doi.org/10.1186/s41256-022-00281-z
Costing interventions in the field: preliminary cost estimates and lessons learned from an evaluation of community-wide mass drug administration for elimination of soil-transmitted helminths in the DeWorm3 trial (Pre-results)
https://doi.org/10.1136/bmjopen-2021-049734
Costs of community-wide mass drug administration and school-based deworming for soil-transmitted helminths: evidence from a randomised controlled trial in Benin, India and Malawi
https://doi.org/10.1136/bmjopen-2021-059565
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1129535)
Article History
Received: 5 April 2022
Accepted: 18 November 2022
First Online: 2 December 2022
Declarations
:
: This study has been reviewed and approved by the Institut de Recherche Clinique au Bénin (IRCB) through the National Ethics Committee for Health Research (002-2017/CNERS-MS) from the Ministry of Health in Benin, The London School of Hygiene and Tropical Medicine (12013), The College of Medicine Research Ethics Committee (P.04/17/2161) in Malawi, and Christian Medical College, Vellore, in India (10392). The study was also approved by The Human Subjects Division at the University of Washington (STUDY00000180).
: Not applicable.
: The authors declare that they have no competing interests.